Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 46, Issue 10, 2011, Pages 1357-1362

  Buhlmann L ^a   Buser, A S ^a,b   Cantoni, N ^a   Gerull, S ^a   Tichelli, A ^a   Gratwohl, A ^a   Stern, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Blood Bank   (Switzerland)

Author keywords

immune reconstitution; NK cells; T cells

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CANCER RELAPSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053940548     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.306     Document Type: Article

References (15)

1. Savani BN, Mielke S, Rezvani K, Montero A, Yong AS, Wish L et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 1216-1223. (Pubitemid 47413017)
2. Powles R, Singhal S, Treleaven J, Kulkarni S, Horton C, Mehta J. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 1998; 91: 3481-3486. (Pubitemid 28193902)
3. Kim DH, Kim JG, Sohn SK, Sung WJ, Suh JS, Lee KS et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 2004; 125: 217-224. (Pubitemid 38534974)
4. Le Blanc K, Barrett AJ, Schaffer M, Hagglund H, Ljungman P, Ringden O et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant 2009; 15: 1108-1115.
5. Chang YJ, Zhao XY, Huo MR, Xu LP, Liu DH, Liu KY et al. Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies. Medicine (Baltimore) 2009; 88: 322-330.
6. Chakrabarti S, Brown J, Guttridge M, Pamphilon DH, Lankester A, Marks DI. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback. Bone Marrow Transplant 2003; 32: 23-30. (Pubitemid 36850276)
7. Savani BN, Mielke S, Adams S, Uribe M, Rezvani K, Yong AS et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 2007; 21: 2145-2152. (Pubitemid 47423804)
8. Kumar S, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ et al. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allo-geneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 2001; 28: 951-956. (Pubitemid 33130238)
9. Matthews K, Lim Z, Pearce L, Pagliuca A, Alejandro Madrigal J, Mufti GJ et al. Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Br J Haematol 2010; 149: 879-889.
10. Lambert C, Cristina I, Christian G. Enumeration of peripheral lymphocyte subsets using 6 vs. 4 color staining: a clinical evaluation of a new flowcytometer. Cytometry B Clin Cytom 2006; 70: 29-38. (Pubitemid 43075996)
11. Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB. Rapid helper T-cell recovery above 2010 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. BoneMarrow Transplant 2006; 37: 1119-1128.
12. Ruggeri L, Capanni M, Mancusi A, Urbani E, Perruccio K, Burchielli E et al. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation. Blood Cells Mol Dis 2004; 33: 216-221. (Pubitemid 39446489)
13. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100. (Pubitemid 34229476)
14. Wang H, Grzywacz B, Sukovich D, McCullar V, Cao Q, Lee AB et al. The unexpected effect of cyclosporin A on CD56+CD16-and CD56+CD16+ natural killer cell subpopulations. Blood 2007; 110: 1530-1539. (Pubitemid 47443969)
15. Berger M, Figari O, Bruno B, Raiola A, Dominietto A, Fiorone M et al. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Bone Marrow Transplant 2008; 41: 55-62.